Streetbeat News

MIRO

Miromatrix Medical Inc

Employees

Industry

Biological Product (except Diagnostic) Manufacturing

miromatrix medical inc. is a life science company that has a novel and proprietary technology to remove cells from, or decellularize, organs and tissues from animal and human sources, facilitating the creation of numerous products, including the potential of fully biological transplantable human organs.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Miromatrix Medical (NASDAQ:MIRO) reported a Q3 EPS loss of $(0.24), missing the $(0.21) estimate, and sales of $11.18K, down from $12.39K YoY, indicating a decrease in performance compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:37 pm

The Dow Jones index gained over 500 points, with Western Digital Corp (WDC) announcing a plan to split its HDD and Flash businesses following upbeat Q1 results. Miromatrix Medical Inc. (MIRO) shares surged after United Therapeutics agreed to acquire the company. VYNE Therapeutics Inc. (VYNE) shares rose after announcing a private placement of $88 million and positive Phase 1b trial data. Eargo, Inc. (EAR) shares increased after announcing it will be taken private by Patient Square Capital. CommScope Holding Company, Inc. (COMM) shares dropped after reporting preliminary Q3 results. Alzamend Neuro, Inc. (ALZN) shares fell after announcing a reverse stock split. LumiraDx Limited (LMDX) shares fell after receiving a Nasdaq delisting determination.

Portfolio Pulse from Lisa Levin

October 30, 2023 | 7:06 pm

The article lists the stocks that have gained and lost the most in Monday's mid-day session. Notable gainers include Miromatrix Medical, Eargo, VYNE Therapeutics, and JinkoSolar Holding, among others, due to various reasons such as acquisitions, private placements, FDA approvals, and strong quarterly results. On the other hand, significant losers include CommScope Holding, LumiraDx, Alzamend Neuro, and ON Semiconductor due to factors like disappointing financial results, Nasdaq delisting, and reverse stock splits.

Portfolio Pulse from Lisa Levin

October 30, 2023 | 5:55 pm

Several healthcare stocks experienced significant price movements during Monday's intraday session. Miromatrix Medical, Eargo, Reviva Pharmaceuticals, Motus GI Hldgs, BioXcel Therapeutics, and VYNE Therapeutics saw their share prices increase, while LumiraDx, Qualigen Therapeutics, Tenax Therapeutics, Better Therapeutics, ABVC BioPharma, and Biotricity experienced declines.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 5:30 pm

U.S. stocks traded higher with the Nasdaq Composite gaining more than 100 points. ON Semiconductor Corporation reported upbeat Q3 results but issued weak Q4 guidance. Miromatrix Medical shares spiked after United Therapeutics agreed to acquire the company. VYNE Therapeutics and Eargo shares also rose following a private placement announcement and a takeover respectively. CommScope Holding Company, Alzamend Neuro, and LumiraDx Limited shares dropped due to preliminary Q3 results, a reverse stock split, and a Nasdaq delisting determination respectively.

Portfolio Pulse from Lisa Levin

October 30, 2023 | 4:14 pm

United Therapeutics (NASDAQ:UTHR) has announced the acquisition of Miromatrix Medical (NASDAQ:MIRO) for $91 million in cash, expected to be completed in Q4 of 2023. United Therapeutics specializes in drug development for pulmonary arterial hypertension, while Miromatrix Medical is a life sciences company pioneering bioengineering fully transplantable organs.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 3:10 pm

United Therapeutics Corporation (NASDAQ:UTHR) has agreed to acquire Miromatrix Medical Inc (NASDAQ:MIRO) for $3.25 per share in cash, totaling approximately $91 million. The deal includes an additional $1.75 per share in cash upon achieving a clinical development milestone related to Miromatrix's mirokidney product by December 31, 2025. The acquisition will expand United Therapeutics' organ manufacturing programs. The transaction is expected to close in Q4 2023.

Portfolio Pulse from Vandana Singh

October 30, 2023 | 2:03 pm

U.S. stocks traded higher with the Dow Jones index gaining over 250 points and NASDAQ rising by 1.20%. McDonald's Corp reported better-than-expected earnings for its third quarter with a sales growth of 14% YoY. Miromatrix Medical Inc. shares shot up 231% after United Therapeutics agreed to acquire the company. VYNE Therapeutics Inc. shares also rose by 52% after the company announced a private placement of $88 million. Eargo, Inc. shares were up by 54% after the company announced it will be taken private by Patient Square Capital. However, CommScope Holding Company, Inc. shares dropped 30% after the company reported preliminary third-quarter financial results. Alzamend Neuro, Inc. and Tenax Therapeutics, Inc. shares also fell by 25% and 21% respectively.

Portfolio Pulse from Lisa Levin

October 30, 2023 | 1:46 pm

In Monday's pre-market session, several healthcare stocks experienced significant movements. Miromatrix Medical, Eargo, VYNE Therapeutics, SELLAS Life Sciences, Motus GI Hldgs, and Reviva Pharmaceuticals saw increases, with Miromatrix leading with a 223.1% rise. On the other hand, Envoy Medical, Lumos Pharma, Revvity, Salarius Pharmaceuticals, Qualigen Therapeutics, and Cardio Diagnostics Hldgs experienced decreases, with Envoy Medical leading the decline with a 14.3% drop.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 1:05 pm

Several stocks are experiencing significant pre-market movements. United Therapeutics Corporation has agreed to acquire Miromatrix Medical for $3.25 per share, causing Miromatrix's shares to jump 232%. Coherus BioSciences and Junshi Biosciences have received FDA approval for LOQTORZI, leading to a 16.2% rise in Coherus' shares. Biophytis S.A. has signed a partnership agreement with Innovation Solutions Pharma, causing its shares to rise 12.7%. On the other hand, Biophytis, The Alkaline Water Company, Medicenna Therapeutics, Nuvve Holding, and Vaxart are among the companies whose shares have fallen in pre-market trading.

Portfolio Pulse from Lisa Levin

October 30, 2023 | 12:44 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.